An Educational Intervention (Lung Toolkit) for Improving Knowledge About Lung Cancer and Screening Among American Indian and Alaskan Native Cigarette Smokers, Lung PATHS Trial

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-80
SponsorFred Hutchinson Cancer Center

About this trial

This clinical trial evaluates the acceptability and effectiveness of an educational intervention (Lung Toolkit) for improving knowledge about lung cancer and lung cancer screening among American Indian/Alaskan Native (AI/AN) cigarette smokers. The Lung Toolkit is an educational intervention, including a website and a physical artifact pouch, specifically tailored to the needs of AI/AN individuals. The website includes evidence-based resources about lung health and lung cancer screening, facts about commercial tobacco and traditional tobacco, national and local smoking cessation and screening resources, and community-building resources such as stories from AI/AN community members about their experiences with lung cancer screening and smoking cessation. The physical artifact pouch links to the website with a quick response code and contains ceremonial herbs and motivational messaging around smoking cessation and lung cancer screening. The Lung Toolkit intervention may be effective for improving knowledge about lung cancer and lung cancer screening among AI/AN cigarette smokers.

Eligibility criteria

Qualifiers

Between ages 50-80

Self-identify as AI/AN

Self-reported 10 pack-year smoking history (commercial tobacco i.e. cigarettes)

Ability to understand and willingness to sign an informed consent document

Disqualifiers

Not between ages 50-80

Having less than a 10 pack-year history of smoking commercial tobacco

Inability to communicate in written and verbal English

Having any cognitive impairment that compromises the ability to provide informed consent

Trial design

Treatments tested in this trial

  • Educational Intervention
  • Educational Intervention
  • Interview
  • Questionnaire Administration

Treatment groups

60 Participants
are divided into 1 treatment group

Sponsors and collaborators

Fred Hutchinson Cancer Center

Lead sponsor

Bristol-Myers Squibb

Collaborator